Genetic variation at NAT2 has been long recognized as the cause of differential ability to metabolize a wide variety of drugs of therapeutic use in diseases with high prevalence such as tuberculosis, arrhythmia and hypertension [6]. The gene discussed is NAT2; the disease is tuberculosis.